| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.41 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
The current challenges in the healthcare sector demand innovative solutions. Point-of-care
devices are emerging as simplified, efficient, and patient-centric alternatives, often using
biosensor technology. SENSO, a miniaturised biosensor, measures inflammation in
Polymyalgia Rheumatica (PMR) patients by detecting the H2O2 concentration in a blood drop.
Its integration into disease monitoring protocols, both on-site and remotely, promises to
enhance patient quality of life while offering an efficient and reliable solution to healthcare
professionals. The SENSO company will use PMR monitoring as a proof-of-concept, starting
with the Iberian market, while assessing the biosensor’s potential for broader applications in
the future.
Descrição
Palavras-chave
Biosensor Hydrogen peroxide Inflammation Polymyalgia rheumatica Disease biomarkers Health monitoring Point-of-care Home care Scientific innovation Science-based entrepreneurship Market segmentation Customer preferences Sales strategy
